provision of professional training, patient care, retail support, supply benefits, pharmacy and digital support and other similar services to retail pharmacies, of the type provided under the “Alphega” brand or any derivations thereof in the Wholesale Distribution Territory as of the date hereof and as of the Closing Date, (d) the provision of specialist supply chain, personalized patient care and homecare solutions, clinical trial and other services to Product manufacturers and clinical research and other similar organizations and individual customers and patients, of the type provided under the “Skills in Healthcare” and “Alcura” brands or any derivations thereof in the Wholesale Distribution Territory as of the date hereof and as of the Closing Date, (e) the sourcing, Manufacture, marketing, distribution, commercialization and sale of generic pharmaceuticals and other Products of the type as engaged in or conducted under the “Almus” and “Alvita” brands or any derivations thereof in the Wholesale Distribution Territory as of the date hereof and as of the Closing Date and (f) the ownership and operation of retail pharmacies in the Retail Territory.
“Confidential Information” has the meaning set forth in Section 5.12.
“Confidentiality Agreement” means, collectively, (a) the Mutual Confidentiality Agreement, dated as of January 1, 2014, by and between Alliance Boots GmbH, a Subsidiary of Seller, and Buyer and (b) the Mutual Confidentiality Agreement, dated as of January 1, 2014, by and between Walgreen Co., a Subsidiary of Seller, and Buyer.
“Consent” means any approval, authorization, consent, ratification, permission, exemption or waiver or the expiration, lapse or termination of any waiting period.
“Contract” means any contract, agreement or other legally binding instrument, including any note, bond, mortgage, deed, indenture, commitment, undertaking, promise, lease, sublease, license or sublicense or joint venture, in each case whether written or oral but excluding any purchaser order.
“Copyrights” has the meaning set forth in the definition of “Intellectual Property.”
“COVID-19” means SARS-CoV-2 or COVID-19, and any evolutions or mutations thereof or any epidemics, pandemic or disease outbreak resulting therefrom.
“COVID-19 Measures” means, with respect to any location, any quarantine, shelter in place, stay at home, workforce reduction, social distancing, shut down, closure, sequester, return to work, employment, human resources or similar Law, Order, directive or guidelines promulgated by any Governmental Body in connection with or in response to COVID-19, including the Coronavirus Aid, Relief and Economic Security Act, to the extent applicable to such location.
“D&O Indemnified Person” has the meaning set forth in Section 5.13(a).
“Data Protection Laws” means any and all Laws relating to data protection, privacy, direct marketing and information security of Personal Data, including the EU GDPR, the Privacy and Electronic Communications Directive 2002/58/EC, together with any national implementing or supplementing laws in the United Kingdom and any Member State of the European Union and any equivalent legislation, or legislation dealing with the same subject matter, anywhere in the world, including the Data Protection Act 2018, the UK GDPR and the Privacy and Electronic Communications (EC Directive) Regulations 2003.
11